Table 1 Characteristics of the study population
Children and adolescents with ADHD (study group) (n = 34) | Children and adolescents without ADHD (control group) (n = 45) | |
|---|---|---|
Gender: | ||
male | 27 (79.4%) | 31 (68.9%) |
female | 7 (20.6%) | 14 (31.1%) |
Age (years): | ||
mean ± SD | 12.38 ± 1.89 | 12.76 ± 1.91 |
median/minimum/maximum | 12/9/15 | 13/9/15 |
Medication for ADHD: | ||
• methylphenidate | 14 (41.2%) | 0 |
• methylphenidate and risperidone | 8 (23.5%) | 0 |
• amphetamine and risperidone | 2 (5.9%) | 0 |
• atomoxetine and risperidone | 2 (5.9%) | 0 |
• no medication | 8 (23.5%) | 45 (100%) |
Months in residential care: | ||
mean ± SD | 21.29 ± 15.74 | 25.24 ± 30.27 |
median/minimum/maximum | 19/0.7/62 | 17/1/149 |
ADHD classification (ICD-10): | ||
F 90.0 | 13 (38.2%) | N/A |
F 90.1 | 20 (58.8%) | N/A |
F 90.8 | 1 (2.9%) | N/A |